J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on August 1, 2007

Papers In Press, published online ahead of print May 2, 2007
J. Lipid Res., doi:10.1194/jlr.M700125-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M700125-JLR200v1
48/8/1710    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, B.
Right arrow Articles by Dietschy, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, B.
Right arrow Articles by Dietschy, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 13, 2007
Revised on April 19, 2007
Accepted on May 1, 2007

Receptor-mediated and bulk-phase lipoprotein endocytosis along with macrophage infiltration contribute to cholesterol accumulation in Niemann-Pick type C disease

Benny Liu, Chonglun Xie, James A. Richardson, Stephen D. Turley, and John M. Dietschy

Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9151

Corresponding Author: john.dietschy{at}utsouthwestern.edu

These studies explored the roles of receptor-mediated and bulk-phase endocytosis as well as macrophage infiltration in the accumulation of cholesterol in the mouse with Niemann-Pick type C disease. Uptake of LDL-cholesterol varied from 514 µg/day in the liver to zero in the CNS. In animals lacking LDL receptors, liver uptake remained about the same (411 µg/day), but more cholesterol was taken up in extrahepatic organs. This uptake was unaffected by the reductive methylation of LDL and consistent with bulk-phase endocytosis. All tissues accumulated cholesterol in mice lacking NPC1 function but this accumulation was decreased in adrenal, unchanged in liver, and increased in organs like spleen and lung when LDL receptor function was also deleted. Over 56 days, the spleen and lung accumulated amounts of cholesterol greater than predicted and these organs were heavily infiltrated with macrophages. Both this accumulation of cholesterol and macrophages was increased by deleting LDL receptor function. These observations indicate that both receptor-mediated and bulk-phase endocytosis of lipoproteins, as well as macrophage infiltration, contribute to the cholesterol accumulation seen in NPC disease. These macrophages may also play a role in parenchymal cell death in this syndrome.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
H. Li, S. D. Turley, B. Liu, J. J. Repa, and J. M. Dietschy
GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice
J. Lipid Res., August 1, 2008; 49(8): 1816 - 1828.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Minahk, K.-W. Kim, R. Nelson, B. Trigatti, R. Lehner, and D. E. Vance
Conversion of Low Density Lipoprotein-associated Phosphatidylcholine to Triacylglycerol by Primary Hepatocytes
J. Biol. Chem., March 7, 2008; 283(10): 6449 - 6458.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Liu, H. Li, J. J. Repa, S. D. Turley, and J. M. Dietschy
Genetic variations and treatments that affect the lifespan of the NPC1 mouse
J. Lipid Res., March 1, 2008; 49(3): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. J. Repa, H. Li, T. C. Frank-Cannon, M. A. Valasek, S. D. Turley, M. G. Tansey, and J. M. Dietschy
Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse
J. Neurosci., December 26, 2007; 27(52): 14470 - 14480.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.